APAC

Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and IlluminaEyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
byMillie Nelson
Feb 18, 2025
4 Min Read
Asian currency
Investment
Eyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and moreEyes on Asia: Ascentage’s IPO, Arrivent & Lepu, Sanofi approval, and more
byMillie Nelson
Feb 3, 2025
4 Min Read
Asia on a world globe
Innovation
Eyes on Asia: AZ C-suite, Verdiva and Sciwind, Korea and China at JPM
Eyes on Asia: AZ C-suite, Verdiva and Sciwind, Korea and China at JPM
Jan 21, 2025
|
5 Min Read
byDan Stanton, Editorial director
magnifying glass focused on China flag
Innovation
China biopharma development still hot & still expanding its reach
China biopharma development still hot & still expanding its reach
Jan 21, 2025
|
4 Min Read
byRichard Daverman, Editor
Image of China banknotes with a magnifying glass indicating dealmaking in Asia
Hubs
Eyes on Asia: BIOSECURE, Merck & Hansoh, Roche adds ADC, and Samsung
Eyes on Asia: BIOSECURE, Merck & Hansoh, Roche adds ADC, and Samsung
Jan 8, 2025
|
5 Min Read
byDan Stanton, Editorial director
Asia currency
Investment
Eyes on Asia: Sanofi expands China footprint; Takeda buys anemia asset
Eyes on Asia: Sanofi expands China footprint; Takeda buys anemia asset
Dec 17, 2024
|
6 Min Read
byRichard Daverman, Editor
China on a clock
Investment
A growing phenomenon: The rise of biopharma NewCos in China
A growing phenomenon: The rise of biopharma NewCos in China
Dec 13, 2024
|
7 Min Read
byRichard Daverman, Editor
Currency
Investment
Eyes on Asia: Merck and BioNTech land Chinese bispecifics
Eyes on Asia: Merck and BioNTech land Chinese bispecifics
Dec 4, 2024
|
4 Min Read
byRichard Daverman, Editor
Money
Investment
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
Eyes on Asia: GSK’s $300m lupus bet, Pfizer’s $1bn China blast
Nov 18, 2024
|
5 Min Read
byRichard Daverman, Editor
Money
Investment
Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
Eyes on Asia: VC hits China, BioStar IPO, and Legend splits from GenScript
Nov 5, 2024
|
3 Min Read
byRichard Daverman, Editor
Reverse arrow
Partnering
Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange
Eddingpharm reverse-merger ‘breakthrough’ for Hong Kong stock exchange
Oct 31, 2024
|
3 Min Read
byRichard Daverman, Editor
Asian currency
Innovation
Eyes on Asia: Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator
Astellas bags gene therapy, AZ a lipoprotein, and a Japanese incubator
Oct 21, 2024
|
4 Min Read
byRichard Daverman, Editor
Eli Lilly logo
Innovation
From east to west: Lilly plans incubators in China and UK
From east to west: Lilly plans incubators in China and UK
Oct 18, 2024
|
2 Min Read
byMillie Nelson, Richard Daverman
Hubs
Eyes on Asia: News from Sanofi, Bayer, AZ plus the return of VC?
News from Sanofi, Bayer, AZ plus the return of VC?
Sep 29, 2024
|
2 Min Read
byRichard Daverman, Editor
Chinese flag — Photo
Investment
China biopharma faces a pause; how bad is it?
China biopharma mid-2023 market summary
Sep 21, 2024
|
4 Min Read
byRichard Daverman, Editor
Investment
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
Eyes on Asia: Eisai $1.5bn pact, OcuMension & Alcon, TYK IPO and more
Sep 18, 2024
|
4 Min Read
byRichard Daverman, Editor
Partnering
Top five Asia biopharma deals: August 2024
Asia biopharma deals: August 2024
Sep 15, 2024
|
4 Min Read
byRichard Daverman, Editor
Partnering
Eyes on Asia: EpimAb sells T-cell, funding for TargetRx, Hygieai on the siRNA march
Eyes on Asia: News from EpimAb, TargetRx, Hygieai
Sep 7, 2024
|
2 Min Read
byRichard Daverman, Editor
Innovation
Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz
Eyes on Asia: UCB portfolio sale, Navigator bags $100m, Bora bulks out CDMO biz
Sep 1, 2024
|
3 Min Read
byRichard Daverman, Editor
Investment
Eyes on Asia: Mulititude out licenses, Huadong bulks up Abs, Merck and Kelun
Eyes on Asia: Multitude out licenses, Huadong bulks up Abs, Merck and Kelun
Aug 25, 2024
|
3 Min Read
byRichard Daverman, Editor

BIO-EUROPE COVERAGE

Novo Nordisk sign
Business Strategy
Lessons and blessings: The Novo Nordisk way
Lessons and blessings: The Novo Nordisk way
Michael May, PhD, President, CCRM discusses Canada as a place for life sciences in this video.
Hubs
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Bridging AI & Life Sciences, Why Investing in Canada Should Be Your Next Move
Shaking hands
Partnering
Picky pharma prone to better proven partners amid dealmaking downturn
Picky pharma prone to better proven partners amid dealmaking downturn
Hervé Ansanay, Biotech Alliance Manager, discusses the features of the RESEAU SATT - SATT NETWORK
Sponsored Content
RESEAU SATT, the Best of French Deep Tech
RESEAU SATT, the Best of French Deep Tech

Latest

Male being kept up at night and unable to sleep
Investment
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Interest rates, IPOs, China, or Trump: What’s keeping investors up at night?
Asia map on the globe
Hubs
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Eyes on Asia: Bain Capital buys MTPC, Merck & Co. halts HPV vax, and Illumina
Francesco De Rubertis, co-founder and partner at Medicxi (left) and Graziano Seghezzi, managing partner at Sofinnova Partners (right).
Investment
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Sofinnova and Medicxi talk M&A, patent cliffs, and China
Mar 17 - Mar 19, 2025
Europe's Largest Springtime Biotech Partnering Event
REGISTER
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
Stay Updated